Utilization and outcomes of nutrient-stimulated hormone therapies in patients undergoing bariatric surgery
Authors' conclusion
Individuals who underwent RYGB and who did not have diabetes had the highest %TWL. Receiving a NuSH prescription both before and after surgery and early NuSH initiation were associated with the greatest %TWL.
Study context
- Population
- Adults who underwent bariatric surgery at a single academic medical center, 2015–2022
- Participants
- 1,638 adults
- Exposure
- Nutrient-stimulated hormone (NuSH) prescriptions before and after surgery vs only after surgery vs no prescriptions
- Outcome
- %TWL over time
Methodological detailssingle academic medical center, linear mixed models
- Single academic medical center
- Linear mixed models
Main finding
As reported in the abstract
Adjusted average %TWL · 72 months
Observational data: associations, not effects.
Further findings
%TWL by surgery type
- RYGB had greater %TWL vs sleeve gastrectomy (SG)
%TWL by diabetes status
- Those without diabetes had greater %TWL vs those with diabetes
%TWL by timing of NuSH initiation
- Greatest %TWL with prescriptions within 6 months after surgery
Original publication
Utilization and outcomes of nutrient-stimulated hormone therapies in patients undergoing bariatric surgery. Int J Obes (Lond). Published 20 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →